التفاصيل البيبلوغرافية
| العنوان: |
Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract. |
| المؤلفون: |
Zhang, Y, Almazi, JG, Ong, HX, Johansen, MD, Ledger, S, Traini, D, Hansbro, PM, Kelleher, AD, Ahlenstiel, CL |
| بيانات النشر: |
MDPI AG |
| سنة النشر: |
2022 |
| المجموعة: |
University of Technology Sydney: OPUS - Open Publications of UTS Scholars |
| مصطلحات موضوعية: |
0399 Other Chemical Sciences, 0604 Genetics, 0699 Other Biological Sciences, Chemical Physics |
| الوصف: |
Since December 2019, a pandemic of COVID-19 disease, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly spread across the globe. At present, the Food and Drug Administration (FDA) has issued emergency approval for the use of some antiviral drugs. However, these drugs still have limitations in the specific treatment of COVID-19, and as such, new treatment strategies urgently need to be developed. RNA-interference-based gene therapy provides a tractable target for antiviral treatment. Ensuring cell-specific targeted delivery is important to the success of gene therapy. The use of nanoparticles (NPs) as carriers for the delivery of small interfering RNA (siRNAs) to specific tissues or organs of the human body could play a crucial role in the specific therapy of severe respiratory infections, such as COVID-19. In this review, we describe a variety of novel nanocarriers, such as lipid NPs, star polymer NPs, and glycogen NPs, and summarize the pre-clinical/clinical progress of these nanoparticle platforms in siRNA delivery. We also discuss the application of various NP-capsulated siRNA as therapeutics for SARS-CoV-2 infection, the challenges with targeting these therapeutics to local delivery in the lung, and various inhalation devices used for therapeutic administration. We also discuss currently available animal models that are used for preclinical assessment of RNA-interference-based gene therapy. Advances in this field have the potential for antiviral treatments of COVID-19 disease and could be adapted to treat a range of respiratory diseases. |
| نوع الوثيقة: |
article in journal/newspaper |
| وصف الملف: |
Electronic; application/pdf |
| اللغة: |
English |
| تدمد: |
1422-0067 |
| Relation: |
http://purl.org/au-research/grants/nhmrc/1175134; Int J Mol Sci; Int J Mol Sci, 2022, 23, (5), pp. 2408; http://hdl.handle.net/10453/155655 |
| الاتاحة: |
http://hdl.handle.net/10453/155655 |
| Rights: |
info:eu-repo/semantics/openAccess |
| رقم الانضمام: |
edsbas.76771090 |
| قاعدة البيانات: |
BASE |
Full Text Finder